The global market for Follicle Stimulating Hormone was estimated to be worth US$ 1275.1 million in 2023 and is forecast to a readjusted size of US$ 1550.6 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030

Follicle Stimulating Hormone - Market

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.

There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Follicle Stimulating Hormone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Follicle Stimulating Hormone by region & country, by Type, and by Application.

The Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Follicle Stimulating Hormone.

Market Segmentation

Scope of Follicle Stimulating Hormone - Market Report

Report Metric	Details
Report Name	Follicle Stimulating Hormone - Market
Forecasted market size in 2030	US$ 1550.6 million
CAGR	2.8%
Forecasted years	2024 - 2030
Segment by Type:	Recombinant FSH Urinary FSH
Segment by Application	Infertility Treatment Assisted Reproductive Technology
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Follicle Stimulating Hormone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Follicle Stimulating Hormone - Market size in 2030?

Ans: The Follicle Stimulating Hormone - Market size in 2030 will be US$ 1550.6 million.

Who are the main players in the Follicle Stimulating Hormone - Market report?

Ans: The main players in the Follicle Stimulating Hormone - Market are Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva

What are the Application segmentation covered in the Follicle Stimulating Hormone - Market report?

Ans: The Applications covered in the Follicle Stimulating Hormone - Market report are Infertility Treatment, Assisted Reproductive Technology

What are the Type segmentation covered in the Follicle Stimulating Hormone - Market report?

Ans: The Types covered in the Follicle Stimulating Hormone - Market report are Recombinant FSH, Urinary FSH

1 Market Overview

1.1 Follicle Stimulating Hormone Product Introduction

1.2 Global Follicle Stimulating Hormone Market Size Forecast

1.2.1 Global Follicle Stimulating Hormone Sales Value (2019-2030)

1.2.2 Global Follicle Stimulating Hormone Sales Volume (2019-2030)

1.2.3 Global Follicle Stimulating Hormone Sales Price (2019-2030)

1.3 Follicle Stimulating Hormone Market Trends & Drivers

1.3.1 Follicle Stimulating Hormone Industry Trends

1.3.2 Follicle Stimulating Hormone Market Drivers & Opportunity

1.3.3 Follicle Stimulating Hormone Market Challenges

1.3.4 Follicle Stimulating Hormone Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Follicle Stimulating Hormone Players Revenue Ranking (2023)

2.2 Global Follicle Stimulating Hormone Revenue by Company (2019-2024)

2.3 Global Follicle Stimulating Hormone Players Sales Volume Ranking (2023)

2.4 Global Follicle Stimulating Hormone Sales Volume by Company Players (2019-2024)

2.5 Global Follicle Stimulating Hormone Average Price by Company (2019-2024)

2.6 Key Manufacturers Follicle Stimulating Hormone Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Follicle Stimulating Hormone Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Follicle Stimulating Hormone

2.9 Follicle Stimulating Hormone Market Competitive Analysis

2.9.1 Follicle Stimulating Hormone Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Follicle Stimulating Hormone Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicle Stimulating Hormone as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Recombinant FSH

3.1.2 Urinary FSH

3.2 Global Follicle Stimulating Hormone Sales Value by Type

3.2.1 Global Follicle Stimulating Hormone Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Follicle Stimulating Hormone Sales Value, by Type (2019-2030)

3.2.3 Global Follicle Stimulating Hormone Sales Value, by Type (%) (2019-2030)

3.3 Global Follicle Stimulating Hormone Sales Volume by Type

3.3.1 Global Follicle Stimulating Hormone Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Follicle Stimulating Hormone Sales Volume, by Type (2019-2030)

3.3.3 Global Follicle Stimulating Hormone Sales Volume, by Type (%) (2019-2030)

3.4 Global Follicle Stimulating Hormone Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Infertility Treatment

4.1.2 Assisted Reproductive Technology

4.2 Global Follicle Stimulating Hormone Sales Value by Application

4.2.1 Global Follicle Stimulating Hormone Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Follicle Stimulating Hormone Sales Value, by Application (2019-2030)

4.2.3 Global Follicle Stimulating Hormone Sales Value, by Application (%) (2019-2030)

4.3 Global Follicle Stimulating Hormone Sales Volume by Application

4.3.1 Global Follicle Stimulating Hormone Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Follicle Stimulating Hormone Sales Volume, by Application (2019-2030)

4.3.3 Global Follicle Stimulating Hormone Sales Volume, by Application (%) (2019-2030)

4.4 Global Follicle Stimulating Hormone Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Follicle Stimulating Hormone Sales Value by Region

5.1.1 Global Follicle Stimulating Hormone Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Follicle Stimulating Hormone Sales Value by Region (2019-2024)

5.1.3 Global Follicle Stimulating Hormone Sales Value by Region (2025-2030)

5.1.4 Global Follicle Stimulating Hormone Sales Value by Region (%), (2019-2030)

5.2 Global Follicle Stimulating Hormone Sales Volume by Region

5.2.1 Global Follicle Stimulating Hormone Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Follicle Stimulating Hormone Sales Volume by Region (2019-2024)

5.2.3 Global Follicle Stimulating Hormone Sales Volume by Region (2025-2030)

5.2.4 Global Follicle Stimulating Hormone Sales Volume by Region (%), (2019-2030)

5.3 Global Follicle Stimulating Hormone Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Follicle Stimulating Hormone Sales Value, 2019-2030

5.4.2 North America Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Follicle Stimulating Hormone Sales Value, 2019-2030

5.5.2 Europe Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Follicle Stimulating Hormone Sales Value, 2019-2030

5.6.2 Asia Pacific Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Follicle Stimulating Hormone Sales Value, 2019-2030

5.7.2 South America Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Follicle Stimulating Hormone Sales Value, 2019-2030

5.8.2 Middle East & Africa Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Follicle Stimulating Hormone Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Follicle Stimulating Hormone Sales Value

6.2.1 Key Countries/Regions Follicle Stimulating Hormone Sales Value, 2019-2030

6.2.2 Key Countries/Regions Follicle Stimulating Hormone Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Follicle Stimulating Hormone Sales Value, 2019-2030

6.3.2 United States Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Follicle Stimulating Hormone Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Follicle Stimulating Hormone Sales Value, 2019-2030

6.4.2 Europe Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Follicle Stimulating Hormone Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Follicle Stimulating Hormone Sales Value, 2019-2030

6.5.2 China Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

6.5.3 China Follicle Stimulating Hormone Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Follicle Stimulating Hormone Sales Value, 2019-2030

6.6.2 Japan Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Follicle Stimulating Hormone Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Follicle Stimulating Hormone Sales Value, 2019-2030

6.7.2 South Korea Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Follicle Stimulating Hormone Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Follicle Stimulating Hormone Sales Value, 2019-2030

6.8.2 Southeast Asia Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Follicle Stimulating Hormone Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Follicle Stimulating Hormone Sales Value, 2019-2030

6.9.2 India Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

6.9.3 India Follicle Stimulating Hormone Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck Serono

7.1.1 Merck Serono Company Information

7.1.2 Merck Serono Introduction and Business Overview

7.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Serono Follicle Stimulating Hormone Product Offerings

7.1.5 Merck Serono Recent Development

7.2 MSD

7.2.1 MSD Company Information

7.2.2 MSD Introduction and Business Overview

7.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)

7.2.4 MSD Follicle Stimulating Hormone Product Offerings

7.2.5 MSD Recent Development

7.3 IBSA

7.3.1 IBSA Company Information

7.3.2 IBSA Introduction and Business Overview

7.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)

7.3.4 IBSA Follicle Stimulating Hormone Product Offerings

7.3.5 IBSA Recent Development

7.4 Ferring

7.4.1 Ferring Company Information

7.4.2 Ferring Introduction and Business Overview

7.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Ferring Follicle Stimulating Hormone Product Offerings

7.4.5 Ferring Recent Development

7.5 Livzon

7.5.1 Livzon Company Information

7.5.2 Livzon Introduction and Business Overview

7.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Livzon Follicle Stimulating Hormone Product Offerings

7.5.5 Livzon Recent Development

7.6 Techwell

7.6.1 Techwell Company Information

7.6.2 Techwell Introduction and Business Overview

7.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Techwell Follicle Stimulating Hormone Product Offerings

7.6.5 Techwell Recent Development

7.7 GenSci

7.7.1 GenSci Company Information

7.7.2 GenSci Introduction and Business Overview

7.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)

7.7.4 GenSci Follicle Stimulating Hormone Product Offerings

7.7.5 GenSci Recent Development

7.8 Gedeon Richter

7.8.1 Gedeon Richter Company Information

7.8.2 Gedeon Richter Introduction and Business Overview

7.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Gedeon Richter Follicle Stimulating Hormone Product Offerings

7.8.5 Gedeon Richter Recent Development

7.9 Teva

7.9.1 Teva Company Information

7.9.2 Teva Introduction and Business Overview

7.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Teva Follicle Stimulating Hormone Product Offerings

7.9.5 Teva Recent Development

8 Industry Chain Analysis

8.1 Follicle Stimulating Hormone Industrial Chain

8.2 Follicle Stimulating Hormone Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Follicle Stimulating Hormone Sales Model

8.5.2 Sales Channel

8.5.3 Follicle Stimulating Hormone Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Follicle Stimulating Hormone Market Trends

Table 2. Follicle Stimulating Hormone Market Drivers & Opportunity

Table 3. Follicle Stimulating Hormone Market Challenges

Table 4. Follicle Stimulating Hormone Market Restraints

Table 5. Global Follicle Stimulating Hormone Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Follicle Stimulating Hormone Revenue Market Share by Company (2019-2024)

Table 7. Global Follicle Stimulating Hormone Sales Volume by Company (2019-2024) & (K Doses)

Table 8. Global Follicle Stimulating Hormone Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Follicle Stimulating Hormone Price by Company (2019-2024) & (USD/Dose)

Table 10. Key Manufacturers Follicle Stimulating Hormone Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Follicle Stimulating Hormone Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Follicle Stimulating Hormone

Table 13. Global Follicle Stimulating Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicle Stimulating Hormone as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Follicle Stimulating Hormone Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Follicle Stimulating Hormone Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Follicle Stimulating Hormone Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Follicle Stimulating Hormone Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Follicle Stimulating Hormone Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Follicle Stimulating Hormone Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)

Table 22. Global Follicle Stimulating Hormone Sales Volume by Type (2019-2024) & (K Doses)

Table 23. Global Follicle Stimulating Hormone Sales Volume by Type (2025-2030) & (K Doses)

Table 24. Global Follicle Stimulating Hormone Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Follicle Stimulating Hormone Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Follicle Stimulating Hormone Price by Type (2019-2024) & (USD/Dose)

Table 27. Global Follicle Stimulating Hormone Price by Type (2025-2030) & (USD/Dose)

Table 28. Global Follicle Stimulating Hormone Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Follicle Stimulating Hormone Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Follicle Stimulating Hormone Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Follicle Stimulating Hormone Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Follicle Stimulating Hormone Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Follicle Stimulating Hormone Sales Volume by Application: 2019 VS 2023 VS 2030 (K Doses)

Table 34. Global Follicle Stimulating Hormone Sales Volume by Application (2019-2024) & (K Doses)

Table 35. Global Follicle Stimulating Hormone Sales Volume by Application (2025-2030) & (K Doses)

Table 36. Global Follicle Stimulating Hormone Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Follicle Stimulating Hormone Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Follicle Stimulating Hormone Price by Application (2019-2024) & (USD/Dose)

Table 39. Global Follicle Stimulating Hormone Price by Application (2025-2030) & (USD/Dose)

Table 40. Global Follicle Stimulating Hormone Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Follicle Stimulating Hormone Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Follicle Stimulating Hormone Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Follicle Stimulating Hormone Sales Value by Region (2019-2024) & (%)

Table 44. Global Follicle Stimulating Hormone Sales Value by Region (2025-2030) & (%)

Table 45. Global Follicle Stimulating Hormone Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030

Table 46. Global Follicle Stimulating Hormone Sales Volume by Region (2019-2024) & (K Doses)

Table 47. Global Follicle Stimulating Hormone Sales Volume by Region (2025-2030) & (K Doses)

Table 48. Global Follicle Stimulating Hormone Sales Volume by Region (2019-2024) & (%)

Table 49. Global Follicle Stimulating Hormone Sales Volume by Region (2025-2030) & (%)

Table 50. Global Follicle Stimulating Hormone Average Price by Region (2019-2024) & (USD/Dose)

Table 51. Global Follicle Stimulating Hormone Average Price by Region (2025-2030) & (USD/Dose)

Table 52. Key Countries/Regions Follicle Stimulating Hormone Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Follicle Stimulating Hormone Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Follicle Stimulating Hormone Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Follicle Stimulating Hormone Sales Volume, (2019-2024) & (K Doses)

Table 56. Key Countries/Regions Follicle Stimulating Hormone Sales Volume, (2025-2030) & (K Doses)

Table 57. Merck Serono Company Information

Table 58. Merck Serono Introduction and Business Overview

Table 59. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 60. Merck Serono Follicle Stimulating Hormone Product Offerings

Table 61. Merck Serono Recent Development

Table 62. MSD Company Information

Table 63. MSD Introduction and Business Overview

Table 64. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 65. MSD Follicle Stimulating Hormone Product Offerings

Table 66. MSD Recent Development

Table 67. IBSA Company Information

Table 68. IBSA Introduction and Business Overview

Table 69. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 70. IBSA Follicle Stimulating Hormone Product Offerings

Table 71. IBSA Recent Development

Table 72. Ferring Company Information

Table 73. Ferring Introduction and Business Overview

Table 74. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 75. Ferring Follicle Stimulating Hormone Product Offerings

Table 76. Ferring Recent Development

Table 77. Livzon Company Information

Table 78. Livzon Introduction and Business Overview

Table 79. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 80. Livzon Follicle Stimulating Hormone Product Offerings

Table 81. Livzon Recent Development

Table 82. Techwell Company Information

Table 83. Techwell Introduction and Business Overview

Table 84. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 85. Techwell Follicle Stimulating Hormone Product Offerings

Table 86. Techwell Recent Development

Table 87. GenSci Company Information

Table 88. GenSci Introduction and Business Overview

Table 89. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 90. GenSci Follicle Stimulating Hormone Product Offerings

Table 91. GenSci Recent Development

Table 92. Gedeon Richter Company Information

Table 93. Gedeon Richter Introduction and Business Overview

Table 94. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 95. Gedeon Richter Follicle Stimulating Hormone Product Offerings

Table 96. Gedeon Richter Recent Development

Table 97. Teva Company Information

Table 98. Teva Introduction and Business Overview

Table 99. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 100. Teva Follicle Stimulating Hormone Product Offerings

Table 101. Teva Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Follicle Stimulating Hormone Downstream Customers

Table 105. Follicle Stimulating Hormone Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Follicle Stimulating Hormone Product Picture

Figure 2. Global Follicle Stimulating Hormone Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Follicle Stimulating Hormone Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Follicle Stimulating Hormone Sales Volume (2019-2030) & (K Doses)

Figure 5. Global Follicle Stimulating Hormone Sales Price (2019-2030) & (USD/Dose)

Figure 6. Follicle Stimulating Hormone Report Years Considered

Figure 7. Global Follicle Stimulating Hormone Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Follicle Stimulating Hormone Players Sales Volume Ranking (2023) & (K Doses)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Follicle Stimulating Hormone Revenue in 2023

Figure 10. Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Recombinant FSH Picture

Figure 12. Urinary FSH Picture

Figure 13. Global Follicle Stimulating Hormone Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Follicle Stimulating Hormone Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Follicle Stimulating Hormone Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)

Figure 16. Global Follicle Stimulating Hormone Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Follicle Stimulating Hormone Price by Type (2019-2030) & (USD/Dose)

Figure 18. Product Picture of Infertility Treatment

Figure 19. Product Picture of Assisted Reproductive Technology

Figure 20. Global Follicle Stimulating Hormone Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Follicle Stimulating Hormone Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Follicle Stimulating Hormone Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)

Figure 23. Global Follicle Stimulating Hormone Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Follicle Stimulating Hormone Price by Application (2019-2030) & (USD/Dose)

Figure 25. North America Follicle Stimulating Hormone Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Follicle Stimulating Hormone Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Follicle Stimulating Hormone Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Follicle Stimulating Hormone Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Follicle Stimulating Hormone Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Follicle Stimulating Hormone Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Follicle Stimulating Hormone Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Follicle Stimulating Hormone Sales Volume (%), (2019-2030)

Figure 37. United States Follicle Stimulating Hormone Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Follicle Stimulating Hormone Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Follicle Stimulating Hormone Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Follicle Stimulating Hormone Sales Value by Application (%), 2023 VS 2030

Figure 43. China Follicle Stimulating Hormone Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

Figure 45. China Follicle Stimulating Hormone Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Follicle Stimulating Hormone Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Follicle Stimulating Hormone Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Follicle Stimulating Hormone Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Follicle Stimulating Hormone Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Follicle Stimulating Hormone Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Follicle Stimulating Hormone Sales Value by Application (%), 2023 VS 2030

Figure 55. India Follicle Stimulating Hormone Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Follicle Stimulating Hormone Sales Value by Type (%), 2023 VS 2030

Figure 57. India Follicle Stimulating Hormone Sales Value by Application (%), 2023 VS 2030

Figure 58. Follicle Stimulating Hormone Industrial Chain

Figure 59. Follicle Stimulating Hormone Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions